Motorsport Games Reports Second Quarter 2024 Financial Results
August 09, 2024 16:10 ET
|
Motorsport Games Inc.
Motorsport Games Inc (NASDAQ:MSGM) reports its second quarter 2024 financial result
FutureFuel Releases Second Quarter 2024 Results
August 09, 2024 16:05 ET
|
FutureFuel Corp.
CLAYTON, Mo., Aug. 09, 2024 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the...
Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
August 09, 2024 16:05 ET
|
Avenue Therapeutics
- Last patient visit complete in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data anticipated in second half of 2024 – - Raised $4.4 million in gross proceeds...
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024 16:05 ET
|
89bio, Inc.
SAN FRANCISCO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of...
Humacyte Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV™) BLA for the Treatment of Vascular Trauma
August 09, 2024 16:05 ET
|
Humacyte, Inc
– 2nd quarter conference call to be held Tuesday, August 13th, at 8:30 a.m. ET – DURHAM, N.C., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage...
Zscaler to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call
August 09, 2024 16:05 ET
|
Zscaler, Inc.
SAN JOSE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, will release fourth quarter and fiscal year 2024 earnings after the market closes on...
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
August 09, 2024 16:05 ET
|
Entera Bio Ltd.
JERUSALEM , Aug. 09, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins,...
Gencor Releases Third Quarter Fiscal 2024 Results
August 09, 2024 16:05 ET
|
Gencor Industries Inc.
ORLANDO, Fla., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) announced today net revenues for the quarter ended June 30, 2024 decreased...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024 16:05 ET
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 09, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024 16:05 ET
|
Vera Therapeutics
BRISBANE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on August 6, 2024, the Compensation Committee granted inducement awards consisting of...
- August 09, 2024 16:04 ET NurExone's ExoPTEN, loaded with siRNA, Demonstrates Ability to Target Injury and Inflammation Sites – New Study
- August 09, 2024 15:49 ET Hemp Seed Meal achieves monumental milestone through AAFCO and FDA-CVM